The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways

Cancer Letters

Volumn 308, Issue 2, 2011, Pages 197-202

  Mancuso, Mariateresa ^a   Leonardi, Simona ^a   Giardullo, Paola ^b   Pasquali, Emanuela ^b   Borra, Fabiana ^a   Stefano, Ilaria De ^c   Prisco, Maria Grazia ^c   Tanori, Mirella ^a   Scambia, Giovanni ^c   Majo, Vincenzo Di ^a   Pazzaglia, Simonetta ^a   Saran, Anna ^a   Gallo, Daniela ^c  

^a ENEA C R CASACCIA   (Italy)

^b GUGLIELMO MARCONI UNIVERSITY   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

17 Estradiol; DPN; PPT; Ptch1; Radiation

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; DIARYLPROPIONITRILE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; MEDULLOBLASTOMA; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL;

MUS;

EID: 79959558098     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.05.004     Document Type: Article

References (25)

1. Kieran M.W., Walker D., Frappaz D., Prados M. Brain tumors: from childhood through adolescence into adulthood. J. Clin. Oncol. 2010, 28:4783-4789.
2. Preston-Martin S., Staples M., Farrugia H., Giles G. Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982-1990: patterns of incidence and survival. Neuroepidemiology 1993, 12:270-279.
3. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 2000-2004. The Central Brain Tumor Registry of the United States, 2008.
4. Prados M.D., Warnick R.E., Wara W.M., Larson D.A., Lamborn K., Wilson C.B. Medulloblastoma in adults. Int. J. Radiat. Oncol. Biol. Phys. 1995, 32:1145-1152.
5. Weil M.D., Lamborn K., Edwards M.S., Wara W.M. Influence of a child's sex on medulloblastoma outcome. JAMA 1998, 279:1474-1476.
6. Curran E.K., Sainani K.L., Le G.M., Propp J.M., Fisher P.G. Gender affects survival for medulloblastoma only in older children and adults: a study from the surveillance epidemiology and end results registry. Pediatr. Blood Cancer 2009, 52:60-64.
7. Goodrich L.V., Milenkovic L., Higgins K.M., Scott M.P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997, 277:1109-1113.
8. Zurawel R.H., Allen C., Wechsler-Reya R., Scott M.P., Raffel C. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice. Genes Chromosomes Cancer 2000, 28:77-81.
9. Pazzaglia S., Mancuso M., Atkinson M.J., Tanori M., Rebessi S., Di Majo V., Covelli V., Hahn H., Saran A. High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice. Oncogene 2002, 21:7580-7584.
10. Mancuso M., Leonardi S., Ceccarelli M., Pasquali E., De Stefano I., Prisco M.G., Rebessi S., Tanori M., Scambia G., Di Majo V., Pazzaglia S., Saran A., Gallo D. Protective role of 17beta-estradiol on medulloblastoma development in Patched1 heterozygous mice. Int. J. Cancer 2010, 127:2749-2757.
11. Stauffer S.R., Coletta C.J., Tedesco R., Nishiguchi G., Carlson K., Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J. Med. Chem. 2000, 43:4934-4947.
12. Meyers M.J., Sun J., Carlson K.E., Marriner G.A., Katzenellenbogen B.S., Katzenellenbogen J.A. Estrogen receptor-beta potency selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J. Med. Chem. 2001, 44:4230-4251.
13. Hahn H., Wojnowski L., Zimmer A.M., Hall J., Miller G., Zimmer A. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat. Med. 1998, 4:619-622.
14. Mancuso M., Pazzaglia S., Tanori M., Hahn H., Merola P., Rebessi S., Atkinson M.J., Di Majo V., Covelli V., Saran A. Basal cell carcinoma and its development: insights from radiation induced tumors in Ptch1 deficient mice. Cancer Res. 2004, 64:934-941.
15. Pazzaglia S., Tanori M., Mancuso M., Gessi M., Pasquali E., Leonardi S., Oliva M.A., Rebessi S., Di Majo V., Covelli V., Giangaspero F., Saran A. Two-hit model for progression of medulloblastoma preneoplasia in patched heterozygous mice. Oncogene 2006, 25:5575-5580.
16. Soldati R., Wargon V., Cerliani J.P., Giulianelli S., Vanzulli S.I., Gorostiaga M.A., Bolado J., do Campo P., Molinolo A., Vollmer G., Lanari C. Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?. Breast Cancer Res. Treat. 2010, 123:709-724. (Epub 2009 December 11).
17. Frasor J., Barnett D.H., Danes J.M., Hess R., Parlow A.F., Katzenellenbogen B.S. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology 2003, 144:3159-3166.
18. Mancuso M., Leonardi S., Tanori M., Pasquali E., Pierdomenico M., Rebessi S., Di Majo V., Covelli V., Pazzaglia S., Saran A. Hair cycle-dependent basal cell carcinoma tumorigenesis in Ptc1neo67/+ mice exposed to radiation. Cancer Res. 2006, 66:6606-6614.
19. Zannoni G.F., Prisco M.G., Vellone V.G., De Stefano I., Scambia G., Gallo D. Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma: a pilot study. Histopathology 2011, 58:265-275.
20. Cardona-Gómez G.P., Mendez P., DonCarlos L.L., Azcoitia I., Garcia-Segura L.M. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res. Rev. 2001, 37:320-334.
21. Rao G., Pedone C.A., Valle L.D., Reiss K., Holland E.C., Fults D.W. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004, 23:6156-6162.
22. Bardin A., Boulle N., Lazennec G., Vignon F., Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer 2004, 11:537-551.
23. Imamov O., Morani A., Shim G.J., Omoto Y., Thulin-Andersson C., Warner M., Gustafsson J.A. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl. Acad. Sci. USA 2004, 101:9375-9380.
24. Nilsen J., Mor G., Naftolin F. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J. Neurobiol. 2000, 43:64-78.
25. Urbanska K., Pannizzo P., Lassak A., Gualco E., Surmacz E., Croul S., Del Valle L., Khalili K., Reiss K. Estrogen receptor beta-mediated nuclear interaction between IRS-1 and Rad51 inhibits homologous recombination directed DNA repair in medulloblastoma. J. Cell Physiol. 2009, 219:392-401.